
Highlights from iwMyeloma 2025: trial updates and practical considerations
VJHemOnc Podcast
00:00
Innovations in Myeloma Treatment
This chapter explores the advancements surrounding ABBV 383, a bi-specific therapy targeting BCMA, which offers new hope for myeloma patients through improved treatment schedules and reduced side effects. The discussion also covers future treatments, such as gamma secretase inhibitors, and the importance of personalized approaches in enhancing treatment efficacy.
Transcript
Play full episode